David HARRISON

Person

Edinburgh, GB

People

Patents Grantslast 30 patents

Information Patent Grant
Selective inhibitors of NLRP3 inflammasome
- Patent number 12,247,011
- Issue date Mar 11, 2025
- NodThera Limited
- Mark G. Bock
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Sulfonylurea derivatives and uses thereof
- Patent number 12,054,461
- Issue date Aug 6, 2024
- NodThera Limited
- Mark G. Bock
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Sulphonyl urea derivatives as NLRP3 inflammasome modulators
- Patent number 12,012,397
- Issue date Jun 18, 2024
- NodThera Limited
- David Harrison
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Sulphonyl urea derivatives as NLRP3 inflammasome modulators
- Patent number 11,518,757
- Issue date Dec 6, 2022
- NodThera Limited
- David Harrison
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Urea derivatives and methods of use thereof
- Patent number 11,345,669
- Issue date May 31, 2022
- NodThera Limited
- David Harrison
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
SELECTIVE INHIBITORS OF NLRP3 INFLAMMASOME
- Publication number 20250223263
- Publication date Jul 10, 2025
- NodThera Limited
- Mark G. BOCK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRROLOPYRIDAZINE DERIVATIVES AND RELATED USES
- Publication number 20250206745
- Publication date Jun 26, 2025
- NodThera Limited
- Mark G. BOCK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRIDAZINE DERIVATIVES AND RELATED USES
- Publication number 20250115558
- Publication date Apr 10, 2025
- NodThera Limited
- Mark G. BOCK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BICYCLIC PHTHALAZIN-1(2H)-ONE DERIVATIVES AND RELATED USES
- Publication number 20250066369
- Publication date Feb 27, 2025
- NodThera Limited
- Mark G. BOCK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SULPHONYL UREA DERIVATIVES AS NLRP3 INFLAMMASOME MODULATORS
- Publication number 20240368129
- Publication date Nov 7, 2024
- NodThera Limited
- David HARRISON
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SULPHAMOYL UREA DERIVATIVES CONTAINING ALKYL-OXACYCLOALKYL MOIETY A...
- Publication number 20240043410
- Publication date Feb 8, 2024
- NodThera Limited
- Mark G. BOCK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SULPHONYL UREA DERIVATIVES AS NLRP3 INFLAMMASOME MODULATORS
- Publication number 20230145050
- Publication date May 11, 2023
- NodThera Limited
- David HARRISON
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SULFONYLUREA DERIVATIVES AND USES THEREOF
- Publication number 20230083495
- Publication date Mar 16, 2023
- NodThera Limited
- Mark G. BOCK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SULFONAMIDE DERIVATIVES AND USES THEREOF
- Publication number 20220267300
- Publication date Aug 25, 2022
- NodThera Limited
- Mark G. BOCK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SULFONYLUREA DERIVATIVES AND USES THEREOF
- Publication number 20220227715
- Publication date Jul 21, 2022
- NodThera Limited
- Mark G. BOCK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CARBAMATE DERIVATIVES AND USES THEREOF
- Publication number 20220098159
- Publication date Mar 31, 2022
- NodThera Limited
- Mark G. BOCK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SELECTIVE INHIBITORS OF NLRP3 INFLAMMASOME
- Publication number 20210087147
- Publication date Mar 25, 2021
- NodThera Limited
- Mark G. BOCK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SULPHONYL UREA DERIVATIVES AS NLRP3 INFLAMMASOME MODULATORS
- Publication number 20210002261
- Publication date Jan 7, 2021
- NodThera Limited
- David HARRISON
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CHEMICAL COMPOUNDS
- Publication number 20200131141
- Publication date Apr 30, 2020
- NodThera Limited
- David HARRISON
- C07 - ORGANIC CHEMISTRY

David HARRISON

Person

Patents Grantslast 30 patents

Selective inhibitors of NLRP3 inflammasome

Sulfonylurea derivatives and uses thereof

Sulphonyl urea derivatives as NLRP3 inflammasome modulators

Sulphonyl urea derivatives as NLRP3 inflammasome modulators

Urea derivatives and methods of use thereof

Patents Applicationslast 30 patents

SELECTIVE INHIBITORS OF NLRP3 INFLAMMASOME

PYRROLOPYRIDAZINE DERIVATIVES AND RELATED USES

PYRIDAZINE DERIVATIVES AND RELATED USES

BICYCLIC PHTHALAZIN-1(2H)-ONE DERIVATIVES AND RELATED USES

SULPHONYL UREA DERIVATIVES AS NLRP3 INFLAMMASOME MODULATORS

SULPHAMOYL UREA DERIVATIVES CONTAINING ALKYL-OXACYCLOALKYL MOIETY A...

SULPHONYL UREA DERIVATIVES AS NLRP3 INFLAMMASOME MODULATORS

SULFONYLUREA DERIVATIVES AND USES THEREOF

SULFONAMIDE DERIVATIVES AND USES THEREOF

SULFONYLUREA DERIVATIVES AND USES THEREOF

CARBAMATE DERIVATIVES AND USES THEREOF

SELECTIVE INHIBITORS OF NLRP3 INFLAMMASOME

SULPHONYL UREA DERIVATIVES AS NLRP3 INFLAMMASOME MODULATORS

CHEMICAL COMPOUNDS